To All,
This is in response to post to post #53 (I am having a problem with my Windows 95 files relative to file "KERNEL32.EXE", and consequently can't access certain URL's or certain features within a Web Site) so please excuse my delay in posting to this thread which has been a "hit-or miss" situation. Hope to have this problem resolved soon.
Well the "die" has been cast and the bears have won this phase of the performance of LCAV. With today's performance, 3 1/4, 2 1/2, 2 3/4, 22,700 shs. (H,L, Current, & vol. as of 15:32 PM EDT), it would seem that the price will deteriorate and languish in a trading range of $3.00 down to $2.625 (or lower if the volume picks up).
Both the short and intermediate MM indicators are in a sell configuration. The long term MM has gone from buy to neutral. OBV has gone from neutral to negative indicating that recent trading activity was "sale on balance". The 'stochastic' indicator is in a "sale and hold" configuration.
A check of other Eximer Eye care stocks shows a general lack of interest in these issues.
So if holders of LCA-Vision stock are willing to stay with this issue for a protracted period of time in the price range of $3.00 to a possible low of $2.25 (price low of Dec. 96), take advantage of any rally to sell this stock.
AS far as the fundamentals for LCAV are concerned, a recent post on this thread indicated that the company was trying to get an extention (or renew) its $12,000,000 credit line. This credit line is neccessary to the continued growth and expansion of LCAV. If the money is raised then the company will continue to grow, but credit can't be raised that will curtail business expansion and the future of LCA-Vision, Inc. Today's price activity has effectively cast a vote of "no confidence" on the company's plans.
I have recently sent an e-mail to Zacks Hot Stocks for their views on the recent news and price performance of LCAV. But, as of this date had no response. Zacks will put out a scheduled report on their recent recommendations on July 25, so maybe we will get their views on the subject.
So let us wait and see for further developments. Sell if you must as it seems the prudent thing to do in the light of lack of positive factors.
Harry |
